IRADIMED Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio36.2434.8027.7161.16204.34
Forward P/E34.5933.9126.0765.0889.41
P/S Ratio9.529.136.6713.648.82
P/B Ratio8.038.384.837.904.56
Price/Tangible Book8.338.694.968.034.63
Price/FCF39.5699.3338.5652.9252.05
Price/OCF27.2044.4435.4050.6648.09
PEG Ratio0.770.770.770.770.77
Enterprise Value Ratios
EV/Revenue8.818.455.6712.287.33
EV/EBITDA28.3426.6218.5445.7570.87
EV/EBIT29.3927.6419.3452.31119.68
EV/FCF36.6491.9232.7847.6643.29
Profitability & Returns
Return on Equity (ROE)0.24%0.24%0.18%0.14%0.02%
Return on Assets (ROA)0.14%0.14%0.12%0.08%0.02%
Return on Invested Capital (ROIC)0.60%0.76%0.82%0.77%0.16%
Return on Capital Employed (ROCE)0.24%0.26%0.20%0.13%0.03%
Leverage & Solvency Ratios
Debt/Equity0.000.030.030.030.04
Debt/EBITDA0.010.100.130.210.74
Debt/FCF0.010.340.240.230.51
Liquidity Ratios
Current Ratio8.844.669.0611.1812.96
Quick Ratio7.383.808.339.9111.50
Efficiency Ratios
Asset Turnover0.770.740.630.540.46
Inventory Turnover1.461.692.492.372.15
Yield & Distribution Ratios
Earnings Yield0.03%0.03%0.04%0.02%0.00%
FCF Yield0.03%0.01%0.03%0.02%0.02%
Dividend Yield0.01%0.00%
Payout Ratio0.71%0.77%0.98%
Buyback Yield0.00%-0.01%0.00%-0.01%-0.01%
Total Return0.00%0.00%0.00%-0.01%-0.01%